<DOC>
	<DOC>NCT02944461</DOC>
	<brief_summary>To determine if Dapsone (Aczone) 7.5% gel is a safe and effective treatment for acne on the trunk</brief_summary>
	<brief_title>Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris</brief_title>
	<detailed_description>This is an open label pilot study to determine the safety and efficacy of Dapsone (Aczone) 7.5% gel applied daily to the trunk for acne. Subjects will apply Dapsone for 16 weeks.</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>Male and female subjects of any race and at least 12 years of age. Female subjects of childbearing potential must have a negative urine pregnancy test at Baseline and practice a reliable method of contraception throughout the study. Truncal acne IGA score of 3. Able to understand the requirements of study and sign Informed Consent/HIPAA forms. Female subjects who are pregnant , breast feeding or are of childbearing potential who are not willing to use a reliable method birth control. Subjects who have an allergy or sensitivity to any component of the test medication. Subjects who have not complied with the proper wash out periods for prohibited medications. Evidence of recent drug or alcohol abuse. Skin disease /disorder that might interfere with the diagnosis or evaluation of truncal acne. Exposure to an investigational drug within 30 days of the Baseline visit. Medical condition that contraindicates the subject's participation in the study. History of poor cooperation, noncompliance with medical treatment or unreliability.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>